ACCESSWIRE
24 Feb 2021, 07:49 GMT+10
PALM HARBOR, FL / ACCESSWIRE / February 23, 2021 / Regener-Eyes®, a leading first-in-class biologic eye drop made of naturally-occurring cytokines and growth factors, today announced the addition of Dr. Art Epstein to its Clinical Advisory Board.
'We are excited to have Dr. Art Epstein join our clinical advisory board. He is a highly respected eye care professional, and will bring valuable insight to our company's efforts,' commented C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes®. 'We are honored to add Dr. Epstein to our existing board alongside our other impressive members, Dr. Marguerite McDonald, Dr. Eric Donnenfeld, Dr. Paul Karpecki, Dr. Walt Whitley, Dr. Scott Schacter and Dr. Ahmed Fahmy.'
Dr. Epstein is the co-founder of Phoenix Eye Care, PLLC and he heads the practice's Dry Eye - Ocular Surface Disease Center - The Dry Eye Center of Arizona and serves as its Director of Clinical Research. He is an Adjunct Associate Professor at Midwestern University Arizona College of Optometry. Active in the profession, Dr. Epstein is a fellow of the American Academy of Optometry and a Distinguished Practitioner of the National Academies of Practice. He is a Diplomate of the American Board of Certification in Medical Optometry, a member of the American and Arizona Optometric Associations and Past-Chair of the AOA Contact Lens & Cornea Section.
About Regener-Eyes®
Regener-Eyes® is a sterile biologic eye drop made of anti-inflammatory cytokines and growth factors. These types of proteins have been shown to reduce inflammation and stimulate the ocular surface to heal, repair, and regenerate. If you have patients that are not responding to current dry eye drugs, amniotic membrane intolerant, or having issues with blood serum tears, many physicians are finding success with Regener-Eyes® as a new option. For more information on our first in class biologic eye drop, please visit us at www.mydryeyes.org, follow us Instagram, like us on Facebook and connect with us on LinkedIn.
Contact Information:
Regener-Eyes®, LLC
Heidi Hart Pukas
heidi.pukas@regenerativeplant.org
SOURCE: Regener Eyes
Get a daily dose of Hawaii Telegraph news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Hawaii Telegraph.
More InformationAn Afghan taxi-driver in Vancouver told one of us a decade ago that this day would come. "We defeated the ...
DES MOINES, Iowa: As the number of Iowa residents who have been vaccinated against Covid rises, the demand has fallen ...
THE HAGUE, Netherlands: Dutch Prime Minister Mark Rutte announced the easing of the country's months-long coronavirus lockdown on Tuesday. A ...
TORONTO, Canada: The province of Ontario, Canada will offer AstraZeneca vaccines to people 40 years and over. This follows a ...
WASHINGTON D.C.: Citing the need to protect U.S. citizens from contracting the Coronavirus, the U.S. State Department said on April ...
NEW YORK, New York: Those who have been inoculated against COVID-19 with the Pfizer vaccine will likely need a third ...
NEW YORK, New York - U.S. stocks tumbled on Friday following news of a new capital gains tax planned by ...
ORLANDO, Florida: April 19 -- Amazon is moving ahead with plans to launch 3,200 satellites to offer Internet services from ...
LONDON, England: Held down by the government's huge jobs subsidies programme, Britain's unemployment rate surprisingly fell for the second month ...
SYDNEY, NSW, Australia - Stocks in Japan took off on Thursday with solid gains also being recorded in Hong Kong ...
WOONSOCKET, Rhode Island: The major American pharmacy chain CVS Health announced this week that it would offer three brands of ...
BANGKOK, Thailand: Thailand is on the brink of putting the finishing touches to one of the largest projects installed atop ...